| A worker is seen at SK Bioscience's plant manufacturing the COVID-19 vaccine of U.S. biotech company Novavax in Andong, North Gyeongsang Province, in this photo. The Ministry of Food and Drug Safety on Wednesday authorized the use of Novavax's COVID-19 vaccine. The protein-based vaccine, Nuvaxovid, is the fifth COVID-19 vaccine to obtain approval for use here. Courtesy of SK Bioscience |